PPARA and age-related macular degeneration: As oxidative stress-induced injuries to RPE are implicated in the progression of AMD [98,99], therapeutic roles of PPARα activation were directly tested in adult retinal pigment epithelial cell line-19 (ARPE-19) using sulindac (one of the first nonsteroidal anti-inflammatory drugs) [100].